×
OSR Holdings Operating Expenses 2022-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OSR Holdings operating expenses from 2022 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
OSR Holdings Operating Expenses 2022-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OSR Holdings operating expenses from 2022 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$146B
CVS Health (CVS)
$90.6B
Elevance Health (ELV)
$69.7B
Cencora (COR)
$58.8B
DiDi Global (DIDIY)
$29.4B
Labcorp Holdings (LH)
$23B
Natera (NTRA)
$22.2B
BioMerieux (BMXMF)
$17.5B
EUROFINS SCIENT (ERFSF)
$15.5B
ICON (ICLR)
$14.2B
Medpace Holdings (MEDP)
$12.7B
CochLear (CHEOY)
$12.7B
Solventum (SOLV)
$12.5B
Viatris (VTRS)
$12.5B
Caris Life Sciences,�Inc (CAI)
$10.7B
Revvity (RVTY)
$10.4B
Avantor (AVTR)
$8.6B
Sonic Healthcare (SKHHY)
$8B
HealthEquity (HQY)
$7.9B
Charles River Laboratories (CRL)
$7.6B
Bausch + Lomb (BLCO)
$5.1B
Sotera Health (SHC)
$4.5B
BrightSpring Health Services (BTSG)
$4.2B
KindlyMD (NAKA)
$4B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.5B
Alignment Healthcare (ALHC)
$3.1B
Concentras Parent (CON)
$2.9B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B